Protalix BioTherapeutics PLX
NYSE PLX
$2.55 -0.02 (-0.78%)
At close: Oct 23, 2026 · 4:00 PM EDT

Protalix BioTherapeutics (PLX) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Protalix BioTherapeutics' Return on Capital Employed [ROCE] was 31.08% in Q2 2026, up 15.29 percentage points from 15.79% a year earlier and up 0.61 percentage points from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Protalix BioTherapeutics came in at -10.71%, down 18.06 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a four-year change of +43.68 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was 7.35% in FY2024 (-35.21 pp), 42.55% in FY2023 (+82.85 pp), -40.29% in FY2022 (+14.09 pp) and -54.39% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last eight quarters, with an average year-over-year change of +3.32 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2023 (a gain of 97.00 percentage points); the worst was Q2 2024 (a drop of 67.90 percentage points).
  • Per Business Quant data, PLX's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 30.47% (Q1 2026), -9.86% (Q4 2025) and 10.90% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 Protalix BioTherapeutics 205.46 Mn 54.08 Mn 12.13 Mn 31.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.08%
Mar 31, 2026 30.47%
Dec 31, 2025 -9.86%
Sep 30, 2025 10.90%
Jun 30, 2025 15.79%
Mar 31, 2025 9.38%
Dec 31, 2024 9.36%
Sep 30, 2024 -17.02%
Jun 30, 2024 -45.20%
Mar 31, 2024 24.96%
Dec 31, 2023 25.85%
Sep 30, 2023 30.43%
Jun 30, 2023 22.70%
Mar 31, 2023 -45.87%
Dec 31, 2022 -54.64%
Sep 30, 2022 -66.57%
Jun 30, 2022 -44.66%
Mar 31, 2022 -52.18%
Dec 31, 2021 -45.07%
Sep 30, 2021 -22.45%
API Access

Protalix BioTherapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PLX&period=max&api_key=YOUR_API_KEY